![]() |
市場調查報告書
商品編碼
1858972
復健機器人市場機會、成長促進因素、產業趨勢分析及預測(2025-2034年)Rehabilitation Robots Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球康復機器人市場價值為 1.354 億美元,預計到 2034 年將以 14.1% 的複合年成長率成長至 5.009 億美元。

推動市場擴張的因素包括:肢體殘疾人數的增加、老年人口的成長、神經系統疾病和創傷相關病例的增多,以及臨床和家庭環境中對機器人復健治療的激增需求。復健機器人正在重塑神經系統疾病、脊髓損傷、手術或與年齡相關的行動障礙後的復健方式。這些機器人系統日益被門診中心、醫院和家庭護理機構所採用,提供針對性的治療,從而增強運動功能和行動能力。感測器整合、即時運動追蹤、人工智慧驅動的響應機制以及雲端治療資料的不斷改進,正將傳統的復健方式轉變為高度個人化和高效的流程。與遠距醫療平台和電子病歷系統的整合,也使治療師和臨床醫生能夠遠端客製化和監測治療方案。隨著需求的成長,各公司正在推出更多符合人體工學、以患者為中心的機器人設備,這些設備採用生物相容性材料製造,並擁有更完善的使用者介面設計。資金投入的增加、有利的醫療保健政策以及持續的產品創新,將繼續支持已開發經濟體和新興經濟體的長期成長。
| 市場範圍 | |
|---|---|
| 起始年份 | 2024 |
| 預測年份 | 2025-2034 |
| 起始值 | 1.354億美元 |
| 預測值 | 5.009億美元 |
| 複合年成長率 | 14.1% |
至2034年,上肢復健市場將以14.4%的複合年成長率成長。推動其成長的主要因素是機器人輔助復健在改善肢體協調性和力量方面的顯著成效。這些系統正被廣泛應用於臨床和復健機構,以支持手臂、肩膀和手部的更快、更有針對性的復原。其日益普及與人們對個人化治療益處以及中風和骨科復健效果提升的認知不斷提高密切相關。
預計到2034年,外骨骼機器人市場將以14.8%的複合年成長率成長。人們對用於輔助行動的穿戴式機器人系統的日益關注,以及脊髓損傷和神經系統疾病發病率的不斷上升,正在推動外骨骼的普及應用。這些系統能夠增強力量、步態訓練和姿勢支撐,其在老年護理、物理治療和傷後復健中的應用正在穩步成長。輕量化材料設計和自適應人工智慧技術的快速發展,使得外骨骼更容易廣泛應用於臨床實踐。
2024年,北美康復機器人市佔率達43.8%。該地區受益於先進的醫療保健生態系統、對機器人創新的高額投資以及對機器人療法益處的廣泛認知。美國在這一區域主導地位中發揮關鍵作用,這得益於其龐大的保險覆蓋範圍、不斷上升的神經肌肉疾病發病率以及將機器人技術融入康復計畫的強力的製度支持。技術開發商與醫學研究機構之間的合作不斷推動技術突破,而機器人技術在長期照護和門診機構的廣泛應用也進一步增強了市場成長動能。
全球康復機器人市場的主要企業包括 Cyberdyne、DIH、REX BIONICS、myomo、KINOVA、Ekso Bionics、FOURIER、tyromotion、BioXtreme、LIFEWARD、BIONIK、LEADERS REHAB ROBOT 和 Rehab-Robotics。這些企業致力於產品創新,透過整合人工智慧演算法、智慧感測器和雲端連接平台,提供個人化和數據驅動的治療方案。領先企業正透過與醫療服務提供者、研究機構和經銷商建立策略合作夥伴關係,拓展其全球業務版圖。研發投入仍是重中之重,旨在開發緊湊、易用且價格合理的設備,以滿足各種復健需求。許多公司正在加強其居家照護服務,並專注於老齡化人口和長期照護市場。
The Global Rehabilitation Robots Market was valued at USD 135.4 million in 2024 and is estimated to grow at a CAGR of 14.1% to reach USD 500.9 million by 2034.

The market's expansion is being driven by the rising number of individuals with physical impairments, a growing elderly population, increasing neurological and trauma-related cases, and the surging demand for robotic rehabilitation across clinical and home settings. Rehabilitation robots are reshaping how recovery is delivered after neurological disorders, spinal cord injuries, surgeries, or age-related mobility challenges. These robotic systems are increasingly adopted in outpatient centers, hospitals, and home care settings, offering targeted therapy that enhances motor recovery and mobility. Continuous improvements in sensor integration, real-time motion tracking, AI-driven response mechanisms, and cloud-enabled therapy data are transforming traditional rehabilitation into a highly personalized and effective process. Integration with telehealth platforms and electronic medical systems is also enabling therapists and clinicians to tailor and monitor treatments remotely. As demand grows, companies are introducing more ergonomic, patient-centric robotic devices built with biocompatible materials and enhanced user interface designs. Increased funding, favorable healthcare policies, and ongoing product innovations continue to support long-term growth across developed and emerging economies.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $135.4 Million |
| Forecast Value | $500.9 Million |
| CAGR | 14.1% |
The upper extremity segment will grow at a CAGR of 14.4% through 2034. Its growth is propelled by the effectiveness of robotic-assisted rehabilitation in improving limb coordination and strength. These systems are being widely implemented in clinical and residential settings to support quicker and more targeted recovery of the arms, shoulders, and hands. Their growing popularity is closely tied to rising awareness of personalized therapy benefits and improved outcomes in stroke and orthopedic rehabilitation.
The exoskeleton robots segment is expected to grow at a CAGR of 14.8% during 2034. Increasing focus on wearable robotic systems for mobility support, coupled with the growing incidence of spinal cord injuries and neurological conditions, is pushing the adoption of exoskeletons. These systems offer enhanced strength, gait training, and posture support, and their use is steadily rising in aging care, physical therapy, and post-injury rehabilitation. Rapid advancements in lightweight material design and adaptive AI capabilities are making them more accessible for widespread clinical deployment.
North America Rehabilitation Robots Market held 43.8% share in 2024. The region benefits from an advanced healthcare ecosystem, high investment in robotics innovation, and broad awareness of robotic therapy's benefits. The United States plays a key role in this regional dominance, with substantial insurance coverage, rising rates of neuromuscular disorders, and strong institutional support for integrating robotic technologies into rehabilitation programs. Partnerships between technology developers and medical research institutions continue to foster breakthroughs, while expanding use in long-term care and outpatient facilities further drives market momentum.
Leading companies in the Global Rehabilitation Robots Market are Cyberdyne, DIH, REX BIONICS, myomo, KINOVA, Ekso Bionics, FOURIER, tyromotion, BioXtreme, LIFEWARD, BIONIK, LEADERS REHAB ROBOT, and Rehab-Robotics. Companies in the Rehabilitation Robots Market are focusing on product innovation by integrating AI algorithms, smart sensors, and cloud-connected platforms to deliver personalized and data-driven therapy. Leading players are expanding their global footprint through strategic partnerships with healthcare providers, research institutions, and distributors. Investment in R&D remains a top priority to develop compact, user-friendly, and affordable devices suitable for diverse rehabilitation needs. Many firms are strengthening their home care offerings, targeting aging populations and long-term care markets.